177 related articles for article (PubMed ID: 15777206)
1. New approach to immunotherapy against organ-specific autoimmune diseases with T cell receptor and chemokine receptor DNA vaccines.
Matsumoto Y
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):73-7. PubMed ID: 15777206
[TBL] [Abstract][Full Text] [Related]
2. Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines.
Matsumoto Y
J Neuroimmunol; 2000 Oct; 110(1-2):1-12. PubMed ID: 11024529
[TBL] [Abstract][Full Text] [Related]
3. Characterization of relapsing autoimmune encephalomyelitis and its treatment with decoy chemokine receptor genes.
Matsumo Y; Sakuma H; Miyakoshi A; Tsukada Y; Kohyama K; Park IK; Tanuma N
J Neuroimmunol; 2005 Dec; 170(1-2):49-61. PubMed ID: 16223531
[TBL] [Abstract][Full Text] [Related]
4. Vaccines for multiple sclerosis: progress to date.
Correale J; Farez M; Gilmore W
CNS Drugs; 2008; 22(3):175-98. PubMed ID: 18278975
[TBL] [Abstract][Full Text] [Related]
5. Successful TCR-based immunotherapy for autoimmune myocarditis with DNA vaccines after rapid identification of pathogenic TCR.
Matsumoto Y; Jee Y; Sugisaki M
J Immunol; 2000 Feb; 164(4):2248-54. PubMed ID: 10657681
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats.
Jee Y; Yoon WK; Okura Y; Tanuma N; Matsumoto Y
J Neuroimmunol; 2002 Jul; 128(1-2):49-57. PubMed ID: 12098510
[TBL] [Abstract][Full Text] [Related]
7. Treatment of autoimmune disease by oral tolerance to autoantigens.
Whitacre CC; Gienapp IE; Meyer A; Cox KL; Javed N
Clin Immunol Immunopathol; 1996 Sep; 80(3 Pt 2):S31-9. PubMed ID: 8811061
[TBL] [Abstract][Full Text] [Related]
8. T cell receptor peptides in treatment of autoimmune disease: rationale and potential.
Vandenbark AA; Hashim GA; Offner H
J Neurosci Res; 1996 Feb; 43(4):391-402. PubMed ID: 8699526
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
[TBL] [Abstract][Full Text] [Related]
10. Reduced chemokine and chemokine receptor expression in spinal cords of TCR BV8S2 transgenic mice protected against experimental autoimmune encephalomyelitis with BV8S2 protein.
Matejuk A; Vandenbark AA; Burrows GG; Bebo BF; Offner H
J Immunol; 2000 Apr; 164(7):3924-31. PubMed ID: 10725756
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor peptide therapy triggers autoregulation of experimental encephalomyelitis.
Offner H; Hashim GA; Vandenbark AA
Science; 1991 Jan; 251(4992):430-2. PubMed ID: 1989076
[TBL] [Abstract][Full Text] [Related]
12. Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines.
Karin N
Curr Opin Mol Ther; 2004 Feb; 6(1):27-33. PubMed ID: 15011778
[TBL] [Abstract][Full Text] [Related]
13. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vbeta8.2 TCR spectratype in the central nervous system of rats with chronic relapsing EAE.
Kim G; Kohyama K; Tanuma N; Arimito H; Matsumoto Y
J Immunol; 1998 Dec; 161(12):6993-8. PubMed ID: 9862735
[TBL] [Abstract][Full Text] [Related]
14. TCR peptide therapy in human autoimmune diseases.
Vandenbark AA; Morgan E; Bartholomew R; Bourdette D; Whitham R; Carlo D; Gold D; Hashim G; Offner H
Neurochem Res; 2001 Jun; 26(6):713-30. PubMed ID: 11519731
[TBL] [Abstract][Full Text] [Related]
15. Vaccines to prevent and treat autoimmune diseases.
Mor F; Cohen IR
Int Arch Allergy Immunol; 1995 Dec; 108(4):345-9. PubMed ID: 7580306
[TBL] [Abstract][Full Text] [Related]
16. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
17. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide.
Buenafe AC; Vainiene M; Celnik B; Vandenbark AA; Offner H
J Immunol; 1995 Aug; 155(3):1556-64. PubMed ID: 7636217
[TBL] [Abstract][Full Text] [Related]
18. Treatment of autoimmune anterior uveitis with recombinant TCR ligands.
Adamus G; Burrows GG; Vandenbark AA; Offner H
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2555-61. PubMed ID: 16723470
[TBL] [Abstract][Full Text] [Related]
19. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE.
Adamus G; Manczak M; Machnicki M
Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2894-903. PubMed ID: 11687534
[TBL] [Abstract][Full Text] [Related]
20. Rational design of peptide vaccines for autoimmune disease: harnessing molecular recognition to fix a broken network.
Weathington NM; Blalock JE
Expert Rev Vaccines; 2003 Feb; 2(1):61-73. PubMed ID: 12901598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
